Skip to main content
Olufemi Adams, MD, Ophthalmology, Greenfield, WI

Olufemi Adams MD

Retinal Disease


Vitreoretinal Surgeon

Join to view full profile
  • 4131 W Loomis RdSte 240Greenfield, WI 53221

  • Phone+1 262-510-0300

  • Fax+1 262-510-0500

Dr. Adams is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Olufemi “Femi” Adams is a fellowship-trained vitreoretinal surgeon at Advanced Retina. He completed vitreoretinal surgery fellowship at the world-renowned Wills Eye Hospital in Philadelphia

    Dr. Adams earned his medical degree from the University of Chicago – Pritzker School of Medicine, following his undergraduate studies at the University of Minnesota – Twin Cities. He completed his internship at Hennepin Healthcare and his ophthalmology residency at the University of Minnesota, where he served in various leadership roles and was awarded the Richard Olson Best Teaching Award every year of residency—a distinction never before achieved in the program’s history.

    At Wills Eye, Dr. Adams received comprehensive training in the medical and surgical management of retinal diseases, including macular degeneration, diabetic retinopathy, retinal detachments, macular holes, and inherited retinal disorders. He was awarded the Heed Ophthalmic Foundation Fellowship, one of the most distinguished and selective honors in ophthalmology. He has authored peer-reviewed publications in leading journals and presented his research at both national and international conferences, contributing to the advancement of the field.

    Dr. Adams has also been recognized for his clinical excellence and commitment to compassionate care, with honors including induction into the Alpha Omega Alpha (AOA) Honor Medical Society and the Gold Humanism Honor Society. He is board-certified by the American Board of Ophthalmology and an active member of both the American Academy of Ophthalmology (AAO) and the American Society of Retina Specialists (ASRS). He is deeply committed to delivering exceptional, personalized care, blending cutting-edge treatments with empathy, integrity, and a collaborative approach.

Education & Training

  • Wills Eye Hospital
    Wills Eye HospitalVitreoretinal Surgery, 2023 - 2025
  • University of Minnesota
    University of MinnesotaResidency, Ophthalmology, 2023
  • Hennepin Healthcare
    Hennepin HealthcareInternship, Transitional Year, 2020
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2019, M.D.
  • University of Minnesota
    University of MinnesotaB.S., B.A., Biochemistry, Physiology, minor in Public Health, Dean’s List, MCAE Gold Academic All-Star, 2011 - 2015

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2023 - 2027
  • WI State Medical License
    WI State Medical License 2025 - 2027
  • PA State Medical License
    PA State Medical License 2023 - 2026
  • MN State Medical License
    MN State Medical License 2019 - 2020
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Heed Ophthalmic Foundation Fellowship Award
  • Richard T. Olson Best Resident Teaching Award (2021, 2022, 2023) University of Minnesota
  • Alpha Omega Alpha Honor Medical Society University of Minnesota, 2022

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The incidence and characteristics of pediatric traumatic hyphema presenting during the COVID-19 pandemic
    Olufemi E Adams, Kristine M Nachbor, Sasha Strul, Journal of American Association for Pediatric Ophthalmology and Strabismus
  • Discontinuous to Continuous Therapy with 0.2 µg/day Fluocinolone Acetonide implant (FAc) Leads to Reduction in Treatment Frequency for Diabetic Macular Edema (DME)
    Adams, Olufemi E., Sidney Schechet, Seenu Hariprasad, Investigative Ophthalmology & Visual Science, Vancouver, Ca

Authored Content

  • Anterior Segment Optical Coherence Tomography Features of KeratitisOctober 2022

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: